COMPANY

Trace Biosciences

HQ: Beaverton, OR source · trace-bio.com ↗ · West Coast

Keywords: From press sources:neurology

Location: Beaverton, OR · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $2.6M.

Sep 3, 2026 NIH award 1R44NS147800-01 FY2026: $448,711 awarded for that fiscal year; activity R44 (SBIR); PI BARTH, CONNOR WILLIAM; recipient as written: TRACE BIOSCIENCES INC, Beaverton, OR. Molecular Imaging of Peripheral and source ↗
May 31, 2024 NIH award 5R44CA247639-04 FY2024: $810,809 awarded for that fiscal year; activity R44 (SBIR); PI BARTH, CONNOR WILLIAM; recipient as written: TRACE BIOSCIENCES INC, Beaverton, OR. Clinical Translation of Near Infrare source ↗
Sep 7, 2023 NIH award 6R44CA247639-03 FY2022: $937,594 awarded for that fiscal year; activity R44 (SBIR); PI BARTH, CONNOR WILLIAM; recipient as written: TRACE BIOSCIENCES INC, Beaverton, OR. Clinical Translation of Near Infrare source ↗
Jul 24, 2023 NIH award 1R43CA272030-01A1 FY2023: $386,211 awarded for that fiscal year; activity R43 (SBIR); PI BARTH, CONNOR WILLIAM; recipient as written: TRACE BIOSCIENCES INC, Beaverton, OR. Two-Color Near-Infrared Fluorescen source ↗

SEC Form D raise Raised $8.33M (Form D filed Aug 12, 2026). SEC Form D 0002147501-26-000002 (Aug 12, 2026)
Evidence (1 event)
- Aug 12, 2026 · SEC Form D 0002147501-26-000002
  Name of Issuer: Trace Biosciences Inc.; CIK: 2147501; Address: Beaverton, OR; Submission type: D; Filing date: 2026-08-12; Industry Group: Biotechnology; Date of First Sale: 2026-07-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 16234498; Total Amount Sold: 8334499; Federal exemptions: 06b
NIH award NIH awarded $449K (SBIR Phase II 1R44NS147800-01, new, notice Sep 3, 2026). NIH RePORTER 1R44NS147800-01 (Sep 3, 2026)
Evidence (1 event)
- Sep 3, 2026 · NIH RePORTER 1R44NS147800-01
  Organization: TRACE BIOSCIENCES INC; City/State: Beaverton, OR; Project number: 1R44NS147800-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-03; FY total cost (award amount): 448711; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Molecular Imaging of Peripheral and Central Nervous System Myelin; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals